Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Monogram has shipped its first mBôs surgical robot to a major global distributor as part of early commercialization efforts outside the US. The company’s technology demonstrated about seven times more stability than current hip replacement techniques in studies with UCLA. No products have received FDA clearance yet; pivotal regulatory milestones are expected in late 2024.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Monogram Orthopaedics.